(Circulation. 2000;102:1931.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
P-Selectin Expression on Platelets Determines Size and Stability of Platelet Aggregates
From the Division of Cardiology (M.M.) and the Division of Hematology (P.T.), Department of Internal Medicine, University of Texas Houston Medical School.
Correspondence to Michael Merten, MD, Division of Cardiology, Department of Internal Medicine, University of Texas Houston Medical School, 6431 Fannin, MSB 5.284, Houston, TX 77030. E-mail michael_merten{at}yahoo.com
Background—P-selectin mediates rolling of platelets and leukocytes on activated endothelial cells. After platelet activation, P-selectin is translocated from intracellular granules to the external membrane, whereas fibrinogen aggregates platelets by bridging glycoprotein (GP) IIb/IIIa between adjacent platelets.
Methods and Results—In this study, we define a novel role for P-selectin in platelet aggregation. Expression of P-selectin on the platelet surface correlated strongly with the mean platelet aggregate size. Inhibition of P-selectin binding to its ligand by either monoclonal anti–P-selectin antibodies directed against the lectin domain or soluble human P-selectin reversed platelet aggregation even when added up to 5 minutes after activation; however, fibrinogen binding to platelets was not affected. This deaggregating effect significantly reduced the maximal size and number of platelet aggregates. When added 1 minute after platelet activation, anti–P-selectin antibody achieved 95% to 100% of the deaggregating effect of EDTA, whereas the anti-GP IIb/IIIa antibody abciximab had no effect. Monoclonal antibodies against known P-selectin ligands, such as P-selectin GP ligand-1 (PSGL-1) or GP Ib, had no effect on platelet aggregation, suggesting a different ligand for P-selectin in platelet aggregate stabilization. In kinetic studies, P-selectin was maximally expressed 10 minutes after platelet activation, whereas maximal activation of GP IIb/IIIa occurred within the first 10 seconds, suggesting that P-selectin operates after fibrinogen binding to activated GP IIb/IIIa.
Conclusions—These results indicate that P-selectin interaction with a ligand, different from PSGL-1 or GP Ib, stabilizes initial GP IIb/IIIa–fibrinogen interactions, allowing the formation of large stable platelet aggregates.
Key Words: platelet-derived factors • glycoproteins • fibrinogen
This article has been cited by other articles:
 |
|
 |
|
  N. Pacienza, R. G. Pozner, G. A. Bianco, L. P. D'Atri, D. O. Croci, S. Negrotto, E. Malaver, R. M. Gomez, G. A. Rabinovich, and M. Schattner The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation FASEB J, April 1, 2008; 22(4): 1113 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Aschbacher, R. von Kanel, P. J. Mills, S. Hong, S. K. Roepke, B. T. Mausbach, T. L. Patterson, M. G. Ziegler, J. E. Dimsdale, S. Ancoli-Israel, et al. Combination of Caregiving Stress and Hormone Replacement Therapy is Associated With Prolonged Platelet Activation to Acute Stress Among Postmenopausal Women Psychosom Med, November 1, 2007; 69(9): 910 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Oostingh, M. Pozgajova, R. J. Ludwig, T. Krahn, W.-H. Boehncke, B. Nieswandt, and M. P. Schon Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions Haematologica, April 1, 2007; 92(4): 502 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Bergmeier, C. L. Piffath, T. Goerge, S. M. Cifuni, Z. M. Ruggeri, J. Ware, and D. D. Wagner The role of platelet adhesion receptor GPIb{alpha} far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis PNAS, November 7, 2006; 103(45): 16900 - 16905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yokoyama, H. Ikeda, N. Haramaki, H. Yasukawa, T. Murohara, and T. Imaizumi Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1280 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Merten, C. Beythien, K. Gutensohn, P. Kuhnl, T. Meinertz, and P. Thiagarajan Sulfatides Activate Platelets Through P-Selectin and Enhance Platelet and Platelet-Leukocyte Aggregation Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 258 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schafer, C. Schulz, M. Eigenthaler, D. Fraccarollo, A. Kobsar, M. Gawaz, G. Ertl, U. Walter, and J. Bauersachs Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion Blood, January 15, 2004; 103(2): 407 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Blann, S. K. Nadar, and G. Y.H. Lip The adhesion molecule P-selectin and cardiovascular disease Eur. Heart J., December 2, 2003; 24(24): 2166 - 2179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. MAZZUCATO, M. R. COZZI, P. PRADELLA, D. PERISSINOTTO, A. MALMSTROM, M. MORGELIN, P. SPESSOTTO, A. COLOMBATTI, L. DE MARCO, and R. PERRIS Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation FASEB J, December 1, 2002; 16(14): 1903 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-A. Tregouet, S. Barbaux, S. Escolano, N. Tahri, J.-L. Golmard, L. Tiret, and F. Cambien Specific haplotypes of the P-selectin gene are associated with myocardial infarction Hum. Mol. Genet., August 15, 2002; 11(17): 2015 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Massaguer, S. Perez-del-Pulgar, P. Engel, J. Serratosa, J. Bosch, and P. Pizcueta Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin J. Leukoc. Biol., August 1, 2002; 72(2): 262 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Valles, M. T. Santos, J. Aznar, M. Martinez, A. Moscardo, M. Pinon, M. J. Broekman, and A. J. Marcus Platelet-erythrocyte interactions enhance alpha IIbbeta 3 integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo Blood, May 13, 2002; 99(11): 3978 - 3984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Horigome, Y. Hiramatsu, O. Shigeta, T. Nagasawa, and A. Matsui Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia J. Am. Coll. Cardiol., March 20, 2002; 39(6): 1072 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Shebuski and K. S. Kilgore Role of Inflammatory Mediators in Thrombogenesis J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 729 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Merten and P. Thiagarajan Role for Sulfatides in Platelet Aggregation Circulation, December 11, 2001; 104(24): 2955 - 2960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wallaschofski, M. Donne, M. Eigenthaler, B. Hentschel, R. Faber, H. Stepan, M. Koksch, and T. Lohmann PRL as a Novel Potent Cofactor for Platelet Aggregation J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5912 - 5919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Barbaux, S. Blankenberg, H. J. Rupprecht, C. Francomme, C. Bickel, G. Hafner, V. Nicaud, J. Meyer, F. Cambien, and L. Tiret Association Between P-Selectin Gene Polymorphisms and Soluble P-Selectin Levels and Their Relation to Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., October 1, 2001; 21(10): 1668 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Smyth, E. D. Reis, W. Zhang, J. T. Fallon, R. E. Gordon, and B. S. Coller {beta}3-Integrin-Deficient Mice but Not P-Selectin-Deficient Mice Develop Intimal Hyperplasia After Vascular Injury : Correlation With Leukocyte Recruitment to Adherent Platelets 1 Hour After Injury Circulation, May 22, 2001; 103(20): 2501 - 2507. [Abstract] [Full Text] [PDF]
|
|